Back to User profile » Dr David A Schwartz
Papers published by Dr David A Schwartz:
Original Research
Adherence rates and health care costs in Crohn's disease patients receiving certolizumab pegol with and without home health nurse assistance: results from a retrospective analysis of patient claims and home health nurse data
Wolf DC, Jaganathan S, Burudpakdee C, Seetasith A, Low R, Lee E, Gucky J, Yassine M, Schwartz DA
Patient Preference and Adherence 2018, 12:869-878
Published Date: 21 May 2018
Review
The PRECiSE 2 trial of certolizumab pegol, a new PEGylated anti-TNF agent, in the treatment of Crohn's disease - An interview with David A Schwartz, 13 June 2007
David A Schwartz
Biologics: Targets and Therapy 2008, 2:125-128
Published Date: 7 March 2008